main content start
Showing Results for: “diabetes exercise”
Breaking Sitting Streaks
Break up sedentary time with light activity to reduce obesity, diabetes, and cardiovascular risks. Check-out moving tips.
Prenatal Care
Explore vital prenatal care strategies for managing diabetes during pregnancy. Learn about blood glucose monitoring, meal planning, insulin use to ensure a healthy pregnancy for you and your baby.
Late Breaking Weight Loss Innovations: New Drug Therapies Shown to Offer Positive Outcomes for Obesity and Type 2 Diabetes Management
Novel Weight Loss Drug, Survodutide, Shows Significant Weight Loss of Nearly 19% At 46 Weeks Oral Semaglutide Demonstrates Weight Loss Up to 15% for People with Obesity and Improved Management of Type 2 Diabetes Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Association’s ® (ADA) 83rd Scientific Sessions in San Diego, CA. Two of the studies were also simultaneously published in The Lancet . This comes at a time when more than 37 million Americans live with diabetes, and nearly 90% of people with diabetes are overweight or
Novel Stem Cell-Derived Islet Cell Therapy Continues to Show Promise for Achieving Insulin Independence for Individuals with Type 1 Diabetes
Stem Cell-Derived Fully Differentiated Islet Cells Shown to Restore Endogenous Insulin Secretion and Improved Glycemic Control in People Living with Type 1 Diabetes Today, findings from the ongoing clinical trial of VX-880, a phase 1/2, multi-center, single-arm, open-label study in patients with type 1 diabetes (T1D) were presented, demonstrating the potential of stem cell-derived islet cell therapy as a future treatment option for patients with T1D. All patients treated with VX-880 had undetectable insulin secretion and a history of recurrent severe hypoglycemic events (SHE) in the year prior
Federal Court Grants Final Approval to Ground-Breaking Settlement That Will Ensure NYC Children with Diabetes Receive Appropriate Care in School
A federal court has approved a landmark settlement that will ensure children with diabetes in New York City receive the care they need to fully participate in school and school-related activities. This class action settlement resolves claims that New York City, the Department of Education, the Department of Health and Mental Hygiene, and the Office of School Health systemically failed to ensure that students with diabetes could attend school safely and have access to the same educational opportunities as their peers, in violation of the Americans with Disabilities Act (“ADA”), Section 504 of
La Asociación Americana de la Diabetes y Genentech Colaboran para Incrementar el Acceso Equitativo a la Salud Ocular
El Proyecto Tiene Como Objetivo Remover Barreras al Acceso a Cuidados de la Salud para Prevenir la Perdida de Visión El día de hoy, la Asociación Americana de la Diabetes (ADA) y Genentech, miembro del Grupo Roche, anunciaron una nueva colaboración como parte del trabajo en el marco de la iniciativa de la ADA “ Health Equity Now ” para hacer frente a la falta de acceso a exámenes médicos y tratamientos para enfermedades oculares que afectan a las personas con diabetes. La diabetes es la principal causa de pérdida de visión en personas entre 18 y 64 años, y las personas afroamericanas
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.